r.mwangi

TL2 · Ghent

Contributes reviews on supplier material. Based in Ghent.

Joined 3 September 2025 · last posted 1d

86 posts, newest first. Showing up to 150.

Journal club: orforglipron phase 2 and the non-peptide question Replied, post #133 · Evidence › Journal club · 26 Jul 2026 · 0 likes Source for the orforglipron phase 2 figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is stronger…
Private prescribing in the UK: what is actually involved Replied, post #76 · Regional › UK & Ireland · 26 Jul 2026 · 0 likes Two claims get bundled together under private prescribing and they need separating. The descriptive one — this is what was observed — is usually well supported. The…
Fixed versus detachable needles: the trade-offs — does this still hold? Replied, post #12 · Devices › Syringes & needles · 20 Jul 2026 · 0 likes Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are more legible for small doses. Larger barrels hold larger volumes. Choose based on…
Tracking a shortage from primary sources rather than rumour Replied, post #107 · Access › Shortages · 17 Jul 2026 · 11 likes Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long the gap will be and how that affects your condition. Discussing with your…
Common supplements people ask about, assessed one at a time Replied, post #49 · Practice › Interactions · 15 Jul 2026 · 23 likes On post #45 — agreed on the reasoning, with one qualification. Supplements and herbs: many have no established interaction. Some do. If you are taking something…
Follow-up: Reading an interaction checker output critically Replied, post #26 · Practice › Interactions · 1 Jul 2026 · 16 likes Research-use-only compounds have no interaction data of any kind, because interaction studies are done on medicines being developed for use in people. It is worth…
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #89 · Evidence › Journal club · 17 Jun 2026 · 25 likes I read post #87 twice before replying, because I had assumed the opposite. Sessions on negative or null results are consistently the most instructive and the hardest to…
Racemisation and why it is invisible to a mass measurement Replied, post #98 · Analytics › Impurities & related substances · 14 Jun 2026 · 20 likes Deletion sequences (incomplete coupling during synthesis): lower in mass by one residue. Chromatographically they usually elute earlier or later depending on the…
I joined for one answer and stayed for a year — what changed my mind Replied, post #17 · Start Here › Welcome · 11 Jun 2026 · 2 likes If you want a fast orientation, read three solved topics in the subcategory you care about. Solved means somebody said the answer worked, which is more signal than…
An appeal that succeeded, with the letter structure Replied, post #6 · Access › Insurance & coverage · 31 May 2026 · 0 likes Taking appeal seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled comparison, and those two…
Prescription portability between countries Replied, post #47 · Access › International · 29 May 2026 · 4 likes Where a jurisdiction has published guidance for clinicians, that document usually answers the practical questions better than any consumer-facing page. It is a small…
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #35 · Practice › Storage & stability · 20 May 2026 · 0 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear.
Reading a trial's population section before its results Replied, post #31 · Evidence › Trials · 18 May 2026 · 23 likes Post #29 describes the usual case. This is about the unusual one. Multiplicity and multiple comparisons: if a trial tests many hypotheses, the chance of a false…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #43 · Practice › Reconstitution · 12 May 2026 · 15 likes Coming back to post #39, because the follow-up matters more than the original answer. Reconstituting the whole vial when you will use a quarter of it is a decision to…
Oral versus injectable exposure: comparing apples to a different fruit — a second dataset Replied, post #15 · Compounds › Oral incretins · 8 May 2026 · 12 likes Anyone comparing published oral and injectable efficacy should check whether the comparison is within one trial or across two. Across two, the populations differ and…
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #13 · Analytics › COA interpretation · 30 Apr 2026 · 0 likes Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not automatically a problem but it is worth noting. Fresh…
Stepping down deliberately, and how to do it without losing progress Replied, post #101 · Practice › Dosing & titration · 29 Apr 2026 · 0 likes The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is off-label by definition. Some people compute it anyway. The…
CJC-1295 with and without DAC: what the modification does Replied, post #44 · Compounds › Secretagogues & GH axis · 28 Apr 2026 · 26 likes On analysis: these are short peptides and generally straightforward chromatographically, which means a poor purity result is more likely to reflect the synthesis than…
Journal club: is percentage weight change the right endpoint? Replied, post #95 · Evidence › Journal club · 23 Apr 2026 · 2 likes Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything…
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #97 · Sourcing › Vendor reports · 21 Apr 2026 · 20 likes Selective submission and selective reporting are the two easiest ways for a result to be shaped, and blinding addresses the first while a commitment to post addresses…
Citation sweep results: how many references did not say what was claimed Replied, post #78 · Meta › Wiki maintenance · 15 Apr 2026 · 2 likes Marking my uncertainty on citation sweep results explicitly. I am confident about the direction, much less confident about the size, and not confident at all that it…
List price versus negotiated price versus what you pay Replied, post #44 · Access › Pricing · 11 Apr 2026 · 7 likes A price well below the rest of the market is a fact rather than a finding, and it is worth noting without concluding from it. This is the sort of thing that ought to be…
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #37 · Evidence › Trials · 8 Apr 2026 · 28 likes The practical version of Subgroup analyses is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions attached.
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #11 · Devices › Syringes & needles · 5 Apr 2026 · 5 likes What I would want before treating 0.3 ml versus 0.5 ml as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the three are…
Choosing which test to pay for, given a fixed budget Replied, post #55 · Sourcing › Independent verification · 5 Apr 2026 · 0 likes It does not extend to lots nobody has seen, it is not a recommendation, and it says nothing about anything other than what was measured. On reflection I would soften…
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #15 · Clinical › Bloodwork · 25 Mar 2026 · 0 likes Liver enzymes: elevation does not specify cause. ALT and AST can rise from many things. Bilirubin helps narrow down the cause. Multiple markers together are more…
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #121 · Access › Pricing · 20 Mar 2026 · 0 likes This follows post #118 rather than contradicting it. List prices versus negotiated prices: the price a pharmaceutical company publishes and the price an insurance…
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #62 · Compounds › Repair & healing peptides · 14 Mar 2026 · 11 likes Reading a preclinical wound-healing model would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
Personal import allowances, compared — a second dataset Replied, post #83 · Access › International · 11 Mar 2026 · 18 likes Two things can be true about Personal import allowances at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument…
Contributing data without breaching anyone's privacy Replied, post #60 · Data & Tools › Datasets · 6 Mar 2026 · 13 likes Anonymisation matters even for volunteered data. A combination of region, dates and a distinctive detail identifies a person more often than people expect. Worth saying…
Pre-registering a personal experiment, seriously — a second dataset Replied, post #37 · Research Methods › N-of-1 designs · 28 Feb 2026 · 2 likes Regression to the mean explains a great many personal experiments. People start when things are at their worst, and things at their worst tend to improve. Someone…
Forced degradation studies: designing one that is informative Replied, post #12 · Analytics › Method validation · 26 Feb 2026 · 22 likes Where I would push back on the forced degradation studies consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
Measurement error in a self-reported exposure Replied, post #17 · Evidence › Study critique · 22 Feb 2026 · 24 likes Post #13 describes the usual case. This is about the unusual one. Attrition is the failure mode most likely to invalidate a result and the least likely to be discussed.…
Second pass at: Submitting a sample: the process end to end Replied, post #9 · Sourcing › Independent verification · 20 Feb 2026 · 1 like Answering the question post #6 raises rather than the one it answers. How to submit a sample: contact the service directly. They will provide instructions on vial type,…
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #16 · Compounds › Tirzepatide · 15 Feb 2026 · 3 likes Thank you — that answers what I came here to find out.
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #25 · Outcomes › Body composition · 9 Feb 2026 · 18 likes Picking up post #24: that is the part I would want checked first. Where the Lean mass preservation discussion usually stalls is that nobody wants to say "I do not know"…
Why this community will not facilitate a group purchase Started this topic · Sourcing › Payments · 7 Feb 2026 · 0 likes Asking directly, because I could not find a straight answer: Why this community will not facilitate a group purchase Currency and fees, set out so that the comparison…
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #18 · Analytics › Mass spectrometry · 26 Jan 2026 · 6 likes This follows post #15 rather than contradicting it. Resolution: "high resolution" commonly means Written quickly, so the reasoning may be tighter than the wording.
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #54 · Documentation › Wiki requests · 25 Jan 2026 · 29 likes Documents that are mostly a worked example age better than documents that are mostly a summary, because the arithmetic does not change.
Aggregates and why a purity assay may miss them entirely Replied, post #45 · Analytics › Impurities & related substances · 2 Jan 2026 · 11 likes Clear enough that I do not think I have a follow-up, which is unusual.
The decimal-point error, and the habit that catches it Replied, post #85 · Practice › Reconstitution · 17 Dec 2025 · 2 likes On decimal-point error, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
Filter needles: when they help and what they cost you Replied, post #4 · Devices › Syringes & needles · 13 Dec 2025 · 22 likes Needle length for subcutaneous delivery is a question about tissue depth and injection angle together. Short needles at ninety degrees and longer ones at an angle reach…
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #32 · Analytics › Method validation · 11 Dec 2025 · 23 likes I would call the community position on Robustness likely rather than established, and I would be comfortable defending that hedge.
Prescription requirements and telehealth models Replied, post #55 · Sourcing › Regulatory · 8 Dec 2025 · 1 like Taking post #54 at face value and following it one step further. Taking prescription requirements and telehealth models seriously for a moment rather than deflecting:…
How to read a phase 2 result without treating it as a phase 3 result Replied, post #7 · Compounds › Retatrutide · 18 Nov 2025 · 1 like I had written a reply contradicting post #3 and deleted it. Here is what survived. Anyone deciding on the basis of what is published should know that what is published…
Where to report an adverse event officially, by region — a second dataset Replied, post #121 · Safety › Adverse events · 11 Nov 2025 · 0 likes A written record of an event with dates is what makes it assessable later, and memory reconstructs sequences that did not happen. The number is defensible. The…
Tracking that stops updating and then resumes Replied, post #37 · Sourcing › Logistics · 18 Oct 2025 · 8 likes Carrier handover between an international and a domestic service is where tracking most often goes quiet, and it is usually silence rather than a problem.
What pooling buys you and what it destroys Replied, post #40 · Evidence › Meta-analyses · 11 Oct 2025 · 13 likes Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be…
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #5 · marked as the solution · Compounds › Cagrilintide & amylin analogues · 30 Sep 2025 · 30 likes On storage: aggregation-prone peptides are the ones where repeated warming and cooling does the most damage, and where a solution that looks fine may already have…
Journal club: STEP-HFpEF and symptom endpoints — a second dataset Replied, post #13 · Evidence › Journal club · 19 Sep 2025 · 2 likes I keep a log for step-hfpef and symptom endpoints specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost…
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #57 · Practice › Dosing & titration · 13 Sep 2025 · 2 likes My position on Escalating every six weeks instead is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
Follow-up: Why appetite effects are mostly central Replied, post #35 · Pharmacology › Receptor biology · 7 Sep 2025 · 18 likes Pharmacological class effects: all GLP-1 agonists slow gastric emptying and suppress appetite. Those are class effects, not unique to one compound. Effects that differ…
Coming back to: Lurking for two months before posting: was that the right call? Replied, post #23 · Start Here › Welcome · 8 Aug 2025 · 12 likes Nothing here requires expertise. The experienced members here got that way by posting questions, not by knowing the answer before they showed up. If you know something…
How to research a compound with no human data without deceiving yourself Replied, post #36 · Compounds › Other compounds · 31 Jul 2025 · 15 likes Post #33 answers the question as asked. The question underneath it is different. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical…
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #87 · Compounds › Semaglutide · 26 Jul 2025 · 10 likes The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It does not appear to correlate with product failure in practice.…
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #16 · Compounds › Retatrutide · 19 Jul 2025 · 2 likes Appreciated. The plain phrasing does more work here than a longer post would.
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #53 · Sourcing › Regulatory · 18 Jul 2025 · 0 likes Nothing in this subcategory is legal advice, and the members who work in regulated environments are the most careful to say so. A modest claim, modestly supported.
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #63 · Compounds › Oral incretins · 13 Jul 2025 · 0 likes Timing consistency matters more for oral dosing than for weekly injection, because absorption depends on the state of the stomach and the state of the stomach varies…
Coming back to: Why semaglutide solutions can look faintly opalescent and when that… Replied, post #4 · Compounds › Semaglutide · 23 Jun 2025 · 0 likes Something worth flagging about semaglutide solutions: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual pattern and…
Needle changes between doses on a reusable pen Replied, post #12 · Devices › Pens & autoinjectors · 3 Jun 2025 · 15 likes I came in to disagree and I am leaving without a disagreement.
Pre-registering a personal experiment, seriously Replied, post #38 · Research Methods › N-of-1 designs · 29 May 2025 · 5 likes The interesting personal experiments are the ones where the answer was no. They are also the ones least likely to be written up. Filing this under things that are true…
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #5 · Data & Tools › Calculators · 16 May 2025 · 22 likes Everything in post #3 holds. The case it does not cover is the one I have. I have no financial interest in anything named in this thread and I want to say so before I…
A well-designed study with a badly written abstract Replied, post #84 · Evidence › Study critique · 15 May 2025 · 0 likes I had written a reply contradicting post #82 and deleted it. Here is what survived. Two people in this thread mean different things by well-designed study and are…
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #13 · Compounds › Repair & healing peptides · 13 May 2025 · 31 likes Post #10 is right about the mechanism and I think understates the practical bit. TB-500 is usually the 7-residue actin-binding fragment of thymosin beta-4, not the full…
Units, standards, and other things that quietly hold the world together Replied, post #38 · Lounge › Off topic · 6 May 2025 · 20 likes Worth separating units as a question about the compound from units as a question about the documentation. They get answered by different people and only one of them is…
Validating a calculator against hand arithmetic — what changed since Replied, post #50 · Data & Tools › Calculators · 5 May 2025 · 9 likes Offering a way to settle Validating a calculator against hand rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the…
Requesting a page: what makes a good request Replied, post #64 · Documentation › Wiki requests · 20 Apr 2025 · 23 likes Picking up post #61: that is the part I would want checked first. Suggesting content for a page: if you know a maintained page is missing something important, post a…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #22 · Evidence › Journal club · 18 Apr 2025 · 0 likes On post #18 — agreed on the reasoning, with one qualification. STEP 1 sits at the boundary between what this community can usefully discuss and what it cannot, and I…
A supplier that answers analytical questions with restated claims Replied, post #51 · Sourcing › Red flags · 4 Apr 2025 · 0 likes Nothing to add, except that this is the answer I would give if asked.
A certificate with no method stated: what can you conclude? Replied, post #16 · Analytics › COA interpretation · 1 Apr 2025 · 11 likes "Not less than 98 per cent" is a specification. "98.3 per cent" is a result. A certificate carrying only the first has not told you what was measured. That is all I can…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #30 · Practice › Reconstitution · 12 Mar 2025 · 8 likes Good question, well framed, and I would like to see it answered properly.
Counter-ion form: the field almost nobody reports — one year on Replied, post #36 · Analytics › COA interpretation · 28 Feb 2025 · 27 likes Counter-ion form belongs on the document and almost never is. Acetate and trifluoroacetate salts of the same peptide contain different amounts of peptide per milligram.
Revisiting: Heart failure with preserved ejection fraction: symptom endpoints Replied, post #8 · Clinical › Comorbidities · 13 Feb 2025 · 26 likes Post #4 put the caveat in the right place and I want to underline it. The practical value of this subcategory is helping somebody frame the question they take to an…
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #41 · Access › International · 12 Feb 2025 · 6 likes Cross-border prescribing and cross-border dispensing are different questions with different answers in most jurisdictions. If this contradicts something upthread, the…
Fixed versus detachable needles: the trade-offs Replied, post #108 · Devices › Syringes & needles · 12 Jan 2025 · 2 likes Taking post #105 at face value and following it one step further. On fixed versus detachable needles, I would rather understate and be corrected upward than overstate…
Research-use-only labelling: what it means and what it does not — the long version Replied, post #56 · Sourcing › Regulatory · 3 Jan 2025 · 9 likes Post #53 is right about the mechanism and I think understates the practical bit. The version of Research-use-only labelling that I was taught turned out to be a…
[2026 update] New subcategory: rationale and scope Replied, post #35 · Meta › Announcements · 1 Dec 2024 · 20 likes Narrowing post #33, because the general version has more than one answer. The edit is clearer. For anyone arriving now, read the edited version — the confusion in the…
Athletes in weight-category sports: a different risk calculus — a second dataset Replied, post #25 · Clinical › Special populations · 23 Nov 2024 · 1 like Narrowing post #23, because the general version has more than one answer. The most useful contribution here is usually a citation to whichever published document comes…
Washout with a one-week half-life: the arithmetic Replied, post #7 · Research Methods › N-of-1 designs · 22 Nov 2024 · 2 likes Generalisability: a robust n-of-1 result applies to you. It does not tell you much about whether the effect generalises to others similar to you, much less to people…
SNAC and the mechanism of oral peptide absorption — the long version Replied, post #8 · Compounds › Oral incretins · 30 Oct 2024 · 24 likes That is a cleaner way of putting what I was circling around.
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #58 · Analytics › Method validation · 24 Oct 2024 · 0 likes The useful distinction on stability-indicating method is between what was measured and what was inferred from it. Both end up in the same sentence and only one of them…
US compounding rules and how they changed Replied, post #17 · Regional › North America · 9 Oct 2024 · 1 like Appeals succeed more often than people expect when they answer the stated criterion point by point and include nothing else. Reading it back, the second half matters…
Why we hide unevidenced fraud accusations and log the hiding Replied, post #4 · Sourcing › Red flags · 7 Oct 2024 · 0 likes Post #2 describes the usual case. This is about the unusual one. The guidelines draw that line for a practical reason as much as a fair one: reports accumulate into…
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #62 · Clinical › Bloodwork · 28 Sep 2024 · 19 likes Reading back through the bring a laboratory threads from last year, the same three questions come up every time and only one of them has ever been answered properly.…
Converting between mg/mL and units per dose, both directions Replied, post #19 · Practice › Reconstitution · 14 Sep 2024 · 2 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does.
How to ask for a dose change without antagonising anyone Replied, post #17 · Clinical › Prescriber conversations · 22 Aug 2024 · 7 likes Fair, and the limits you put on it are the part I will remember.